These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3320952)

  • 1. [Criteria for assessing granulocytic or platelet cytopenia caused by drugs. Results of consensus meetings].
    Solal-Céligny P; Benichou C; Boivin P; Castot A; Coulombel L; Danan G; Degos L; Evreux JC; Lagier G; Lavarenne J
    Nouv Rev Fr Hematol (1978); 1987; 29(4):265-70. PubMed ID: 3320952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Criteria of imputation of acute hepatitis to a drug. Results of consensus meetings].
    Danan G; Bénichou C; Begaud B; Biour M; Couzigou P; Evreux JC; Lagier G; Berthelot P; Benhamou JP
    Gastroenterol Clin Biol; 1987; 11(8-9):581-5. PubMed ID: 3308618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug-induced renal insufficiency. Results of consensus meetings].
    Vigeral P; Baumelou A; Bénichou C; Castot A; Danan G; Kreft-Jais C; Lagier G; Rothschild E; Druet P; Grünfeld JP
    Nephrologie; 1989; 10(3):157-61. PubMed ID: 2691914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia.
    Int J Clin Pharmacol Ther Toxicol; 1991 Feb; 29(2):75-81. PubMed ID: 2026468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting.
    Benichou C; Solal Celigny P
    Nouv Rev Fr Hematol (1978); 1991; 33(3):257-62. PubMed ID: 1956763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-induced cutaneous photosensitivity. Results of a consensus meeting].
    Roujeau JC; Beani JC; Dubertret L; Guillaume JC; Jeanmougin M; Danan G; Lagier G; Benichou C
    Therapie; 1989; 44(3):223-7. PubMed ID: 2528839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interstitial pneumopathies: criteria of drug side-effects. Results of consensus meetings].
    Fournier M; Camus P; Benichou C; Danan G; Begaud B; Castot A; Lagier G; Brune J; Pariente R; Chrétien J
    Presse Med; 1989 Sep 2-9; 18(27):1333-6. PubMed ID: 2529493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The importance of the clinical differential diagnosis in the evaluation of a suspected drug reaction].
    Kuhn M; Hartmann K; Gartmann J
    Schweiz Rundsch Med Prax; 1991 Nov; 80(45):1255-6. PubMed ID: 1947563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):317-22. PubMed ID: 2272712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criteria of drug-induced liver disorders. Report of an international consensus meeting.
    Bénichou C
    J Hepatol; 1990 Sep; 11(2):272-6. PubMed ID: 2254635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine-induced leucopenia and thrombocytopenia.
    Shankar BR
    Psychosomatics; 2007; 48(6):530-1. PubMed ID: 18071101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regional Centers of Pharmacovigilance: a complementary source of efficiency].
    Mazé F; Bégaud B
    Therapie; 1998; 53(4):397-400. PubMed ID: 9806011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protamine-induced thrombocytopenia and leukopenia.
    Al-Mondhiry H; Pierce WS; Basarab RM
    Thromb Haemost; 1985 Feb; 53(1):60-4. PubMed ID: 3873119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug induced cytopenias].
    Palleschi M; Palleschi A; D'Amore F
    Clin Ter; 1967 Dec; 43(5):481-90. PubMed ID: 4389842
    [No Abstract]   [Full Text] [Related]  

  • 16. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden.
    Wester K; Jönsson A; Spigset O; Hägg S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):173-80. PubMed ID: 16739241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of granulocyte colony-stimulating factor (filgrastim) in the treatment of non-cytotoxic drug-induced agranulocytosis.
    Wickramanayake PD; Scheid C; Josting A; Katay I; Schulz A; Diehl V
    Eur J Med Res; 1995 Dec; 1(3):153-6. PubMed ID: 9445760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions.
    Blomqvist P; Feltelius N; Ekbom A; Klareskog L
    J Rheumatol; 2000 May; 27(5):1171-7. PubMed ID: 10813283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.